热门资讯> 正文
VolitionRx提议承销公开发行普通股、普通股认购证
2025-10-10 04:14
- VolitionRx (NYSE:VNRX) is proposing to offer and sell, in an underwritten public offering, shares of its common stock and accompanying common stock purchase warrants.
- The final terms of the proposed offering will depend on market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
- Volition intends to use the net proceeds from the offering for research and continued product development, clinical studies, product commercialization, working capital and other general corporate purposes, including potential strategic acquisitions.
- VNRX -2.04% after hours to $0.5887.
- Source: Press Release
More on VolitionRX
- VolitionRX reports Q2 results
- VolitionRx prices $1.2M registered direct offering
推荐文章
资金复盘 | 北水回流抄底！净买入港股超128亿港元，抢筹阿里、腾讯、中芯国际
“大空头”清仓，巴菲特疯狂囤积现金！当前美股泡沫有多少？
一周财经日历 | 下周必看！全球股王英伟达将揭晓财报，小鹏、小米、拼多多也轮番登场
新股暗盘 | "新能源材料龙头"中伟新材跌约1.5%，预计该股将于11月17日正式挂牌上市
全文|B站Q3业绩会实录：B站有国内最好的AI创作者及用户
华盛早报 | 美联储放鹰，美股全线大跌！腾讯、京东财报超预期，B站扭亏为盈
美股机会日报 | 阿里巴巴拟改版“千问”对标ChatGPT！思科盘前大涨7%，业绩超预期并上调指引
“木头姐”买入逾2500万美元阿里巴巴股票，继续减持特斯拉
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
